TGFB1 and COVID-19: Nevertheless, implications of this important study could include the monitoring of plasma TGF-β levels in COVID-19 patients and test whether they could serve as an early indicator of disease progression as well as the possible use of TGF-β blockers in the treatment of COVID-19.